Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
/in Dendritic Cells, International Publications, Pancreatic CancerThe future of cancer vaccines against colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsNeoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
/in Dendritic Cells, International Publications, NSCLCRecent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease VirusAn Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
/in Dendritic Cells, Gallbladder Cancer, International PublicationsDendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial
/in Dendritic Cells, Endometrial Cancer, International PublicationsDendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report
/in Dendritic Cells, International Publications, NSCLCA systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
/in Dendritic Cells, Glioblastoma, International PublicationsGlioblastoma vaccines: past, present, and opportunities
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer